Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.700
+0.210 (14.09%)
At close: Aug 13, 2025, 4:00 PM
1.620
-0.080 (-4.71%)
Pre-market: Aug 14, 2025, 9:15 AM EDT
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$1,361
Profits / Employee
-$654,935
Market Cap
86.63M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INO News
- 1 day ago - Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 3 days ago - Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP) - PRNewsWire
- 9 days ago - INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025 - PRNewsWire
- 5 weeks ago - INOVIO to Present at Upcoming Scientific Conference - PRNewsWire
- 6 weeks ago - INOVIO Announces Pricing of $25 Million Public Offering - PRNewsWire
- 6 weeks ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 6 weeks ago - Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development - GlobeNewsWire